Related by context. Frequent words. (Click for all words.) 73 Phase 2a clinical 72 Phase Ib 72 Phase 1b 71 dose escalation study 71 Phase 2b study 71 Phase IIa 70 Phase 2a 69 Phase III clinical 69 Phase IIa clinical 69 Phase IIb 69 Phase IIa trial 69 Phase IIb clinical 69 Phase 2b trial 68 Phase 2b clinical 67 Phase IIb trial 67 pivotal Phase III 67 Phase 2b 66 RDEA# 66 safety tolerability 65 randomized placebo controlled 65 placebo controlled 65 dose escalation 65 pharmacokinetic 64 Phase III 64 pivotal Phase 64 IDX# 63 double blind placebo 63 PRX # 63 randomized Phase 63 blind randomized placebo 62 Phase II 62 initiate Phase 62 clinical trial 61 tolerability 61 pharmacokinetic profile 61 IND enabling 60 RG# [001] 60 pharmacodynamics 60 Phase III clinical trials 60 pharmacokinetics 60 randomized double 59 pharmacodynamic 59 ISIS # 59 CK # 59 XL# [003] 58 ADX# 58 mg dose 58 randomized controlled 58 Phase 58 investigational drug 58 investigational compound 57 Zerenex 57 DSMB 57 IMGN# 57 blind randomized 57 AEZS 57 Phase III trials 57 unblinded 57 AP# [003] 57 ofatumumab 57 blind placebo controlled 57 randomized clinical 57 perifosine 57 immunogenicity 57 orally administered 56 preclinical 56 CRx 56 oral formulation 56 MGCD# [001] 56 tolerability profile 56 randomized 56 preclinical studies 56 laquinimod 56 AZD# 56 LEVADEX 56 monotherapy 56 multicenter 55 voreloxin 55 HspE7 55 mg doses 55 carfilzomib 55 CYT# 55 ANA# 55 ARRY 55 INCB# [002] 55 Marqibo 55 NDA submission 54 ALKS 54 clinical trials 54 relapsing remitting multiple sclerosis 54 ALTU 54 primary efficacy endpoint 54 TMC# [001] 54 PMX # 54 mipomersen 54 CBLB# 54 ITMN 54 antiviral activity 54 Androxal 54 MB# [004] 53 Clinical Study